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Abstract
Background
Acute kidney injury (AKI) is a commonly recognized clinical problem after congenital heart
disease (CHD) surgery. Increased perioperative morbidity, development of chronic kidney
disease, and increased mortality are the major concerns. We investigated frequency, risk
factors, and outcomes of AKI after CHD surgery at our hospital.

Methods
This study was a retrospective analytic review conducted from January 2013 to October 2016 on
patients aged between 1 month and 45 years who underwent cardiopulmonary bypass (CPB) for
CHD surgery. The modified Kidney Disease Improving Global Outcomes criteria based on serum
creatinine value was adopted to diagnose AKI. We assessed AKI frequency and its staging, and
outcomes as AKI resolution, length of stay, and mortality. Stages II and III (plasma creatinine
level two or more times the baseline) were labeled as severe AKI. Univariate and multivariate
logistic regression analyses were conducted, and results were reported as mean with standard
deviation and as frequencies with percentage. Odds ratios (ORs) with 95% confidence intervals
(CIs) were reported for factors associated with the development of AKI.

Results
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Of the 840 patients who underwent CHD surgery, 237 (28%) developed AKI. AKI stages II1 and
III were seen in 101 (42%) and 103 (43%) patients, respectively. Prolonged CPB time > 120
minutes (adjusted OR [AOR]: 1.87; 95% CI: 1.22-2.88; p = 0.004) and hemoglobin > 16 gm/dL
(AOR: 1.80; 95% CI: 1.16-2.78; p = 0.008) were associated with the development of AKI on
multivariate analysis. AKI resolved spontaneously in 222 (94%) patients, and 10 (4%) patients
who developed AKI died.

Review ended 04/11/2020
Published 04/18/2020

Conclusions
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Most patients with AKI showed spontaneous resolution. Prolonged CPB time and increased
hemoglobin were found to be significant risk factors. Our study found spontaneous resolution
of AKI in most cases. However, preplanning and careful monitoring in patients with expected
prolonged CPB time and increased baseline hemoglobin can prevent and identify AKI at an
early stage.
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Introduction
Acute kidney injury (AKI) is a common illness after congenital heart disease (CHD) surgery. The
reported incidence of AKI in this population is high, ranging from 30% to 52%, with the highest
incidence in neonates (60%) post-CHD surgery [1-3]. Concerns are related to not only increased
risk of in-hospital mortality but also increased risk of morbidities leading to chronic renal
failure, prolonged mechanical ventilation, prolonged stay in the intensive care unit, and
resultant high cost of care [4]. Risk factors associated with AKI include prolonged
cardiopulmonary bypass (CPB) time, complexity of surgical repair, degree of hypothermia,
circulatory arrest, and postoperative low cardiac output syndromes [2-4]. A major advancement
in the field of AKI research has been the development of standardized, staged definitions of
AKI that allow for comparison of incidence and outcomes across studies.
AKI has been defined using various classifications including Pediatric Risk, Injury, Failure,
Loss, End-Stage Renal Disease (RIFLE) criteria, Kidney Disease Improving Global Outcomes
(KDIGO) criteria, and Acute Kidney Injury Network (AKIN) [5,6-9]. Luo et al. in their
prospective study concluded that KDIGO is better than RIFLE and as good as AKIN [8]. Patients
with AKI diagnosed by KDIGO but missed by RIFLE or AKIN had higher mortality than those
without AKI, according to KDIGO [2,10,11]. The m-KDIGO is the revised form adapted to
prevent noise and bias toward classifying critically ill young infants and neonates in terms of
the presence of AKI. It uses a minimum serum creatinine of >0.5 mg/dL to successfully identify
AKI [8,9].
Pediatric CHD services are in the beginning stage in Pakistan. There is a scarcity of resources
for managing these complex patients. Many CHDs are left unrepaired on time, and there is
often delay in diagnosis and surgery of these patients. The objective of our study was to
determine the frequency, risk factors, and outcomes of AKI in the immediate postoperative
period after CHD surgery. It will not only help in understanding the burden of this morbidity
but would also be able to modify some of these factors, reduce cost, and provide preemptive
management of at-risk groups, leading to better outcomes.

Materials And Methods
A retrospective analytic review was conducted at Aga Khan University Hospital (AKUH) after
approval from the hospital’s ethical review committee; exemption from full review and consent
was granted because of the retrospective nature of the study. AKUH is a 700-bed private tertiary
care referral center for specialized adult and pediatric care, where approximately 250 CHD
surgeries are performed annually. It has a four-bed pediatric cardiac intensive care unit (PCICU)
staffed with a full-time intensivist and round-the-clock coverage. All patients undergoing
congenital heart surgery are admitted to the PCICU. All three modalities of renal replacement
therapy (RRT) are available here, including peritoneal dialysis, hemodialysis, and continuous
RRT.
A medical record review was conducted from January 2013 to October 2016 of all patients who
underwent CHD surgery on CPB. Patient age ranged from 1 month to 45 years. This wider age
range was considered because the burden of late-presenting adult CHD in low- to middleincome countries is high, and these patients thus comprise a substantial percentage of CHD
surgeries at our center.
Patients who had existing renal dysfunction (already on RRT or with glomerular filtration rate <
60 mL/minute/1.73 m2 for more than three months), those who died within 24 hours, those
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older than 45 years, and those (>18 years) with diabetes mellitus and hypertension were
excluded. We also excluded neonatal CHD patients in order to prevent skewed results because
the first few days of creatinine level reflect maternal creatinine level followed by a fall in
creatinine. However, if AKI is present, creatinine may not fall, resulting in the rise in creatinine
not being detected, thus leading to fewer cases detected and secondly the criterion of a
minimum serum creatinine of 0.5 mg/dL at baseline. The baseline level in some neonates may
be lower than 0.5 mg/dL; thus, they will not be included in the study. Therefore, the suggested
definition in this paper may result in the detection of fewer cases of neonatal AKI. Cardiac
surgical procedures were graded as 1-6 by complexity based on the Risk Adjustment for
Congenital Heart Surgery (RACHS-1). RACHS-1 was chosen because it is the standard score
used at our center for reporting outcomes [12]. Vasoactive inotropic score (VIS) was calculated
as described by Gaies et al., and a score of >20 was labeled as high VIS [13-15]. The medication
profile of all patients was examined to find drugs that have nephrotoxicity as their adverse
effect. Data were collected using a structured proforma and extracted from the patients’
medical records. Patients were identified from the intensive care unit log-book and rechecked
with a health information management system using the International Classification of
Diseases coding. Data collection included demographic details (age, gender, weight, height) as
well as clinical details including anatomical and physiological cardiac diagnosis, RACHS
scoring, surgical procedure details, CPB and aortic cross-clamp (ACC) time, blood transfusion,
inotropic support, nephrotoxic drug exposure, laboratory variables (creatinine, hemoglobin),
and outcome data (staging of AKI, need of RRT, resolution of AKI and mortality).
The m-KIDGO criteria were used to define AKI and stages. AKI was defined on the basis of mKIDGO criteria, and an increase in serum creatinine level by 0.3 mg/dL or more and a minimum
serum creatinine of > 0.5 mg/dL was required at baseline to be included in the study. Stage I was
defined as an increase in serum creatinine level by 0.3 mg/dL or more, up to 1.5 to 1.9 times the
baseline. Stage II was defined as an increase in serum creatinine to 2.0 to 2.9 times the baseline,
and Stage III was defined as an increase in serum creatinine to 3.0 times or more of the
baseline.
No AKI was defined as baseline serum creatinine that did not increase by 0.3 mg/dL or more
from baseline within seven days of CHD surgery. The maximum AKI stage was defined based on
the increase in serum creatinine criteria. Urine output as a determinant of AKI was not used
because 95% of the patients in our unit received a diuretic within 12 hours of arriving at the
PCICU, which has the potential of bias and could change the results. A CPB time of >120
minutes was defined as prolonged CPB time [16]. Existing renal dysfunction was labeled in
patients who had a history of chronic renal failure, those with high baseline serum creatinine
(laboratory range > 1.3 mg/dL), or those who were on RRT before surgery.
Patients were followed for the first seven days of CHD surgery for the development of AKI, need
for RRT, and in-hospital mortality. Complete resolution was defined as a return of serum
creatinine to <50% above baseline. Similarly, an incomplete resolution was defined as serum
creatinine decreased but remained >50% above baseline during their length of stay.
Statistical analysis was conducted using Stata Statistical Software, Release 12 (StataCorp LP,
College Station, TX, USA). The chi-square test for categorical variables and the Student t-test
for continuous variables were used. The univariate and multivariable analyses were conducted
using logistic regression to assess the relationship of independent variables with the log odds
of the outcome variable. Crude and adjusted odds ratios (AORs) with 95% confidence interval
(CI) were reported. P-value of less than 0.05 was considered statistically significant. Results are
presented as the frequency with percentages and as mean with standard deviation.

Results
2020 Ali et al. Cureus 12(4): e7727. DOI 10.7759/cureus.7727

3 of 11

A total of 840 patients underwent CHD surgery on CPB during the study period, of which 237
(28%) developed AKI. The study population included 474 patients (calculated sample size: 237
with AKI and 237 without AKI). The mean age of the study population was 8.2 ± 9.3 years and
7.6 ± 9.5 years in the AKI and no AKI groups, respectively. Male patients comprised 151 (63.7%)
of the 237 patients in the AKI group and 167 61.9%) of the 237 patients (in the no AKI group.
Cyanotic CHD was present in 106 (45%) of the 237 patients in the AKI group compared with 92
(38%) of the 237 patients in the no AKI group (Table 1). AKI stage III was present in 103
patients (43%; Table 2). Of 237 patients, 222 (94%) had spontaneous resolution of AKI, while
worsening of AKI was seen in 15 (6%) patients. Of the 15 patients, 5 (2%) showed resolution on
follow-up, and RRT (peritoneal dialysis) was performed in three patients. Ten (4%) patients
died. Complete resolution occurred in 137 patients (62%; Table 3). Also, 156 patients (66%)
developed AKI in the first 24 hours, and 152 patients (64%) had peak time of AKI in the first 24
hours (Table 2). The mean duration to AKI resolution was 4.2 ± 2.4 days. The mean length of
hospital stay was 8.0 ± 4.1 days in the AKI group compared with 5.1 ± 2.5 days in the no AKI
group (p = 0.000). On univariate analysis, prolonged CPB time, multiple CPB time, multiple ACC
time, RACHS-1, and preoperative hemoglobin > 16 gm/dL were associated with the
development of AKI (Table 4). On multivariate logistic regression analysis, prolonged CPB time
(>120 minutes; AOR: 1.87; 95% CI: 1.22-2.88; p = 0.004) and hemoglobin > 16 gm/dL (AOR:
1.80; 95% CI: 1.16-2.78; p = 0.008) were independently associated with AKI (Table 3).
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Variable

AKI, n (%)/Mean ± SD

Non-AKI, n (%)/Mean ± SD

p-Value

Age (years)

8.2 ± 9.3

7.6 ± 9.5

0.50

30 days to 1 month

59 (24.8)

45 (18.9)

>1 to 5 years

69 (29.1)

100 (42.1)

>5 to 10 years

38 (16)

41 (17.3)

>10 to 18 years

47 (19.8)

29 (12.2)

>18 to 30 years

16 (6.7)

15 (6.3)

>30 to 45 years

8 (3.3)

7 (2.9)

Weight (kg)

21.2 ± 18.7

7.6 ± 9.5

0.50

Height (cm)

107 ± 36.7

103 ± 32

0.30

Gender (male)

151 (63.7)

149 (62.8)

0.55

1

29 (12.3)

52 (22)

0.02

2

177 (74.6)

166 (70)

0.10

3

25 (10.5)

17 (97.2)

0.28

4

6 (2.5)

2 (0.8)

0.60

Cyanotic heart disease

106 (45)

92 (38)

0.12

Acyanotic heart disease

131 (55)

145 (61)

0.13

Single ventricle

8 (3.4)

14 (6)

0.14

Preoperative creatinine (mmol/dL)

0.3 ± 0.1

0.4 ± 0.2

0.01

Preoperative hemoglobin (mg/dL)

14.2 ± 0.2

13.5 ± 0.1

0.02

Cardiopulmonary bypass time (minutes)

111.6 ± 3.7

83.5 ± 2.3

0.00

Aortic cross-clamp time (minutes)

73.4 ± 2.5

54 ± 2.3

0.00

Age groups

0.09

RACHS

TABLE 1: Comparison of baseline data for AKI versus non-AKI performed using
Pearson’s chi-square test for categorical variables and Student’s t-test for continuous
variables
AKI, acute kidney injury; SD, standard deviation; RACHS, Risk Adjustment for Congenital Heart Surgery
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Variables

N (%)/(Mean ± SD)

AKI stages
Stage 1

33 (15)

Stage 2

101 (42)

Stage 3

103 (43)

AKI outcome
AKI worsening

15 (6)

Resolution

5 (2)

Expired

10 (4)

Spontaneous resolution

222 (94)

Complete resolution

137 (62)

Incomplete resolution

27 (13)

No follow-up

58 (27)

Length of stay (mean ± SD)
Case

8 ± 4.1

Control

5.1 ± 2.5

Day of AKI diagnosis
Day 1

156 (66)

Day 2

36 (16)

Day 3

32 (14)

Day 4

4 (2)

Day 5

2 (2)

Time to peak AKI postdiagnosis
Day 1

152 (64)

Day 2

48 (20)

Day 3

24 (10)

Day 4

4 (2)

Day 5

9 (4)

Duration of AKI
1 day

9 (4)

2 days

56 (24)
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3 days

65 (28)

4 days

28 (12)

5 days

5 (3)

6 days

3 (1)

7 days

4 (2)

>7 days

56 (24)

Do not know

4 (2)

TABLE 2: Detail of AKI stages and outcomes
AKI, acute kidney injury
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Variables

Crude OR

95% CI

p-Value

Age (years)

1.0

0.99-1.03

0.50

<2

0.8

0.60-1.27

0.48

<5

0.7

0.52-1.08

0.12

Weight (kg)

1.0

0.99-1.03

0.47

Height (cm)

1.0

0.99-1.02

0.23

Gender

1.0

0.6-1.4

0.84

Preoperative UP (mL/kg/minutes)

1.1

0.83-1.51

0.44

Preoperative Hb (gm/dL)

1.0

0.99-1.12

0.05

Prior operation

0.5

0.25-1.28

0.12

RACHS-1 risk category 1

11.3

1.30-99.03

0.02

RACHS-1 risk category 2

5.7

0.68-47.79

0.10

RACHS-1 risk category 3

3.3

0.37-30.79

0.28

Cyanotic

1.3

0.9-1.83

0.23

Single ventricle

0.5

0.2-1.35

0.26

CPB time (minutes)

1.0

1.00-1.04

0.00

Prolonged CPB time (>120 minutes)

3.0

1.53-3.42

0.00

ACC time (minutes)

1.0

1.00-1.02

0.00

Multiple CPB

4.0

1.4-11.0

0.00

Multiple ACC

4.5

1.2-16.0

0.02

Modified ultra-filtrate

0.5

0.3-0.75

0.00

Need of blood transfusion

1.8

0.83-4.23

0.15

On arrival high inotropic score

1.0

1.00-1.06

0.01

On-arrival hypotension

1.4

0.6-3.10

0.34

Use of nephrotoxic antibiotics

1.9

0.9-3.67

0.05

TABLE 3: Univariate analysis for risk factors of acute kidney injury
OR, odds ratio; CI, confidence interval; UP, urine output; Hb, hemoglobin, RACHS, Risk Adjustment for Congenital Heart Surgery;
CPB, cardiopulmonary bypass; ACC, aortic cross-clamp
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Variable

Adjusted OR

95% CI

p-Value

Prolonged CPB time (>120 minutes)

1.87

1.22, 2.88

0.00

Preoperative Hb (>16 gm/dL)

1.80

1.16, 2,78

0.00

TABLE 4: Multivariate analysis: risk adjusted for acute kidney injury
OR, odds ratio; CI, confidence interval; CPB, cardiopulmonary bypass; Hb, hemoglobin

Discussion
Our study reported an overall frequency of AKI of approximately 28% after congenital heart
surgery, without any association with mortality and morbidity. The frequency was lower than
earlier reports, which may be due to our excluding the neonatal population in which the risk
was highest. Ueno et al. also used m-KIDGO criteria and found 37.5% AKI in the infant
population [11]. Another study by Sethi et al. used the AKIN criteria, as well as serum creatinine
and baseline renal functions to define AKI based on the Schwartz formula [12]. This study did
not use urine output due to the use of diuretics postoperatively. They reported an AKI
prevalence of 9.6%, and most patients had stage I AKI. All patients with AKI recovered their
kidney function at the time of discharge, with normal blood pressure. However, their study did
not define the postoperative recovery course of their patients, although other studies did not
have significant numbers of stage III AKI patients with spontaneous resolution [12,16,17]. We
reported a slightly different observation: the majority (85%) of our patients were in stages II
and III AKI according to the m-KDIGO classification, and 94% showed spontaneous resolution.
Of the AKI cases, 6% worsened and required RRT; among the worsened cases, only 10 (4%)
patients died. Twenty-seven percent of the patients were lost to follow-up. No further serum
creatinine levels were used to document either complete resolution or the presence of residual
AKI. Loss of follow-up and non-compliance to medical advice are also hidden factors for worse
outcomes in low- to middle-income countries. To prevent bias and overdiagnosis of AKI, we
used the m-KIDGO criteria, which required a minimum serum creatinine value of >0.5 mg/dL in
order to be defined as AKI, as the recent literature supports the use of this definition for the
diagnosis of AKI. Our age distribution also did not show a significant difference in the younger
age group (i.e., nearly 54% of the patients younger than five years old). Of the affected cases,
87% belonged to RACHS-1 and RACHS-2, and almost half (45%) had cyanotic heart disease,
whereas other reports had the majority of their patients in RACHS-2 and RACHS-3 [11,14]. The
majority (66%) of AKI patients were diagnosed on their first postoperative day, and 64% of
patients had their peak serum creatinine level within 24 hours after AKI diagnosis, which is
similar to previous reports [14]. This highlights the important fact that AKI after CHD surgery
was a common but self-limiting problem in most of the cases, but it can be associated with
morbidity and increased resource utilization [1,2].
On multivariate analysis, prolonged CPB time and high hemoglobin were found to be
independent risk factors. Li et al. found an interesting linear relationship between increasing
bypass time and increasing AKI [2]. The association between prolonged CPB time and high
hemoglobin (>16 gm/dL) could be explained by the presence of cyanotic heart disease in almost
half of our study population, and our study population was older compared with that in
previous reports. Severe, prolonged hypoxia can possibly affect the kidneys preoperatively,
which manifests in the postoperative period. Another possible explanation could be the
possibility of reperfusion injury; therefore, high hemoglobin is just a marker of severe hypoxia,
which, in turn, is associated with AKI.
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Many of the patients in our study were not monitored through follow-up in the clinic with a
repeat creatinine level, which is mandatory in patients who have developed AKI after CHD
surgery to detect residual disease and development of chronic kidney disease. We cannot
comment on patients who were lost to follow-up or were diagnosed as stage II or III AKI based
on an increase in serum creatinine. However, this study is the first of its kind to have
highlighted the hidden facts, clinical outcomes, and shortcomings related to AKI patients from
a low- to middle-income country. AKI is best managed with early detection and appropriate
treatment to prevent associated morbidity and chronic kidney disease. There is considerable
variability in clinical practices. Clinical practice guidelines in the ﬁeld thus have the potential
to reduce variations, improve outcomes, and reduce costs.
There are some limitations in this study that could be addressed in future research. First, we
included both pediatric and adult populations with the intent to perform a subgroup analysis
for risk of AKI; however, this analysis could not be conducted possibly due to the paucity of
adult AKI cases. Secondly, this was a single-center study with limited follow-up data; hence,
the management of our center cannot be generalized to the entire population. Thirdly, there
was a vast range of different cardiac surgeries, which we grouped into cyanotic, acyanotic, and
single-ventricle heart diseases, and this made it difficult to correlate the type of surgery with
the development of AKI. Lastly, we did not use urine output as a definition for AKI since many
patients received diuretics, and this might have affected the accuracy of urine output as a
variable for the definition of AKI.

Conclusions
We found a high frequency of AKI after CHD surgery, and it was significantly associated with
prolonged CPB time and high hemoglobin after congenital heart surgery. Though the majority
of patients showed spontaneous resolution, not all were able to fulfill the complete resolution
criteria. Therefore, proper clinical practice guidelines should be practiced in low- to middleincome countries to identify the risk factors and associations. This will make us more aware of
the likelihood of developing AKI post-CHD surgery and thus allow earlier management of AKI,
leading to reduced morbidity and mortality. We recommend that every postoperative patient be
checked for AKI based on standard criteria. Regular follow-ups should be conducted for all AKI
cases to determine long-term outcomes.

Additional Information
Disclosures
Human subjects: Consent was obtained by all participants in this study. Aga Khan University
Hospital Ethical Review Committee issued approval 4505-Ped-ERC-16. Animal subjects: All
authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of
interest: In compliance with the ICMJE uniform disclosure form, all authors declare the
following: Payment/services info: All authors have declared that no financial support was
received from any organization for the submitted work. Financial relationships: All authors
have declared that they have no financial relationships at present or within the previous three
years with any organizations that might have an interest in the submitted work. Other
relationships: All authors have declared that there are no other relationships or activities that
could appear to have influenced the submitted work.

References
1.

2.

Blinder JJ, Goldstein SL, Lee VV, Baycroft A, Fraser CD, Nelson D, Jefferies JL: Congenital
heart surgery in infants: effects of acute kidney injury on outcomes. J Thorac Cardiovasc Surg.
2012, 143:368-374. 10.1016/j.jtcvs.2011.06.021
Li S, Krawczeski CD, Zappitelli M, et al.: Incidence, risk factors, and outcomes of acute kidney

2020 Ali et al. Cureus 12(4): e7727. DOI 10.7759/cureus.7727

10 of 11

3.

4.

5.

6.

7.

8.
9.

10.
11.

12.

13.
14.

15.

16.

17.

injury after pediatric cardiac surgery: a prospective multicenter study. Crit Care Med. 2011,
39:1493-1499. 10.1097/CCM.0b013e31821201d3
Esch JJ, Salvin JM, Thiagarajan RR, Del Nido PJ, Rajagopal SK: Acute kidney injury after
Fontan completion: risk factors and outcomes. J Thorac Cardiovasc Surg. 2015, 150:190-197.
10.1016/j.jtcvs.2015.04.011
Chiravuri SD, Riegger LQ, Christensen R, Butler RR, Malviya S, Tait SR, Voepel-Lewis T:
Factors associated with acute kidney injury or failure in children undergoing cardiopulmonary
bypass: a case-controlled study. Pediatr Anaesth. 2011, 21:880-886. 10.1111/j.14609592.2011.03532.x
Ricci Z, Di Nardo M, Iacoella C, Netto R, Picca S, Cogo P: Pediatric RIFLE for acute kidney
injury diagnosis and prognosis for children undergoing cardiac surgery: a single-center
prospective observational study. Pediatr Cardiol. 2013, 34:1404-1408. 10.1007/s00246-0130662-z
Kellum JA, Lameire N: KDIGO AKI Guideline Work Group: Diagnosis, evaluation, and
management of acute kidney injury: a KDIGO summary (Part 1). Crit Care. 2013, 17:204.
10.1186/cc11454
Lex DJ, Tóth R, Cserép Z, et al.: A comparison of the systems for the identification of
postoperative acute kidney injury in pediatric cardiac patients. Ann Thorac Surg. 2014,
97:202-210. 10.1016/j.athoracsur.2013.09.014
Luo X, Jiang L, Du B, et al.: A comparison of different diagnostic criteria of acute kidney injury
in critically ill patients. Crit Care. 2014, 18:144. 10.1186/cc13977
Selewski DT, Cornell TT, Heung M, et al.: Validation of the KDIGO acute kidney injury criteria
in a pediatric critical care population. Intensive Care Med. 2014, 40:1481-1488.
10.1007/s00134-014-3391-8
Selewski DT, Charlton JR, Jetton JG, Guillet R,Mhanna MJ, Askenazi DJ, Kent AL: Neonatal
acute kidney injury. Pediatrics. 2015, 136:463-473. 10.1542/peds.2014-3819
Ueno K, Seki S, Shiokawa N, et al.: Validation of acute kidney injury according to the modified
KDIGO criteria in infants after cardiac surgery for congenital heart disease. Nephrology
(Carlton). 2019, 24:294-300. 10.1111/nep.13240
Sethi SK, Kumar M, Sharma R, Bazaz S, Kher V: Acute kidney injury in children after
cardiopulmonary bypass: risk factors and outcome. Indian Pediatr. 2015, 52:223-226.
10.1007/s13312-015-0611-4
Sethi SK, Goyal D, Yadav DK, et al.: Predictors of acute kidney injury post-cardiopulmonary
bypass in children. Clin Exp Nephrol. 2011, 15:529-534. 10.1007/s10157-011-0440-2
Aydin SI, Seiden HS, Blaufox AD, Parnell vA, Choudhury T, Punnoose A, Schneider J: Acute
kidney injury after surgery for congenital heart disease. Ann Thorac Surg. 2012, 94:1589-1595.
10.1016/j.athoracsur.2012.06.050
Gaies MG, Gurney JG, Yen AH, et al.: Vasoactive-inotropic score as a predictor of morbidity
and mortality in infants after cardiopulmonary bypass. Pediatr Crit Care Med. 2010, 11:234238. 10.1097/PCC.0b013e3181b806fc
Blinder JJ, Asaro LA, Wypij D, Selewski DT, Agus MSD, Gaies M, Ferguson MA: Acute kidney
injury after pediatric cardiac surgery: a secondary analysis of the safe pediatric euglycemia
after cardiac surgery trial. Pediatr Crit Care Med. 2017, 18:638-646.
10.1097/PCC.0000000000001185
Cardoso B, Laranjo S, Gomes I, et al.: [Acute kidney injury after pediatric cardiac surgery: risk
factors and outcomes. Proposal for a predictive model]. Rev Port Cardiol. 2016, 35:99-104.
10.1016/j.repc.2015.06.006

2020 Ali et al. Cureus 12(4): e7727. DOI 10.7759/cureus.7727

11 of 11

